A groundbreaking device developed in Melbourne is poised to transform how pregnant women and their babies are monitored, allowing for convenient at-home assessments. This innovative technology connects to a smartphone via Bluetooth, providing instant feedback for both the patient and healthcare provider.
Dr. Emerson Keenan from KALI Healthcare described the device as a set of adhesive dots placed on the abdomen that measure electrical activity. This allows for the monitoring of the fetal heart rate, maternal heart rate, and uterine contractions. As a modern alternative to traditional ultrasound methods, this device aims to offer greater freedom and less disruption in monitoring.
Dr. Fiona Brownfoot noted that standard ultrasound technology has been in use since the 1960s, but its effectiveness can be compromised by movement from the mother or baby, leading to signal loss. The new device, to be employed from 32 weeks of gestation, will require clinical oversight, either in a hospital setting or via telehealth, to provide reassurance during high-risk pregnancies.
Around 60 per cent of pregnancies experience complications that necessitate more thorough monitoring. Christina Morris, who is 38 weeks pregnant and considered high-risk due to her age and previous IVF treatment, expressed the anxiety that can accompany pregnancy. She highlighted the need for reassurance, particularly when monitoring fetal movements.
The device’s preliminary trials will take place at Epworth Freemasons Maternity Hospital before expanding to additional facilities. Developers are optimistic about securing approval from the Therapeutic Goods Administration (TGA), expecting the device to be available for use by late next year. This advancement is expected to bring significant peace of mind to expectant mothers, allowing them to monitor their health and their baby’s without the constraints of traditional methods.